Some functions of this side are available with javascript only!
Medicine
Radiology
Molecular Pharmacology & Chemistry Program
Pathology
Neurosurgery
Human Oncology & Pathogenesis Program (HOPP)
Surgery
Cell Biology Program
Cancer Biology & Genetics Program
Structural Biology Program
Medicine - Breast Cancer Medicine Service
Developmental Biology Program
Epidemiology & Biostatistics
Neurology
Pediatrics
Service Facilities
Molecular Biology Program
Medical Physics
Laboratory Medicine
Benzenesulfonates
Protein Kinase Inhibitors
Antineoplastic Agents
Pyrroles
Piperazines
Indoles
Pyrimidines
Cyclin-Dependent Kinase 6
Protein-Tyrosine Kinases
Cyclin-Dependent Kinase 4
Proto-Oncogene Proteins c-abl
Phthalazines
Angiogenesis Inhibitors
Sirolimus
Enzyme Inhibitors
Retinoblastoma Protein
Vascular Endothelial Growth Factor A
Fusion Proteins, bcr-abl
Receptors, Vascular Endothelial Growth Factor
Cyclin-Dependent Kinase Inhibitor p18
Phosphotransferases
Farnesyltranstransferase
Piperidines
Proto-Oncogene Proteins B-raf
Extracellular Signal-Regulated MAP Kinases
Norsteroids
Anilides
Pyrazoles
Histone Deacetylase Inhibitors
Von Hippel-Lindau Tumor Suppressor Protein
Fluorouracil
fms-Like Tyrosine Kinase 3
Antibodies, Monoclonal
Carcinoma, Renal Cell
Kidney Neoplasms
Liver Neoplasms
Carcinoma, Hepatocellular
Drug Eruptions
Oligodendroglioma
Hand-Foot Syndrome
Neoplasms
Antineoplastic Combined Chemotherapy Protocols
Drug Resistance, Neoplasm
Maximum Tolerated Dose
Drug Administration Schedule
Disease-Free Survival
Neoplasm Staging
Phosphorylation
Foot
Clinical Trials, Phase III as Topic